Clinical Trial Detail

NCT ID NCT02673736
Title A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Plexxikon
Indications

Advanced Solid Tumor

tenosynovial giant cell tumor

Therapies

AC708

Age Groups: adult

No variant requirements are available.